S, H., H, C., H, C., S, A., HY, Y., & JS, S. (2026). Leucettine L41 Ameliorates Tau pathology and neuroinflammation in Parkinson's disease models. BMC neuroscience. https://doi.org/10.1186/s12868-026-01026-1
Chicago Style (17th ed.) CitationS, Hwang, Choi H, Cho H, Ahn S, Yun HY, and Song JS. "Leucettine L41 Ameliorates Tau Pathology and Neuroinflammation in Parkinson's Disease Models." BMC Neuroscience 2026. https://doi.org/10.1186/s12868-026-01026-1.
MLA (9th ed.) CitationS, Hwang, et al. "Leucettine L41 Ameliorates Tau Pathology and Neuroinflammation in Parkinson's Disease Models." BMC Neuroscience, 2026, https://doi.org/10.1186/s12868-026-01026-1.
Warning: These citations may not always be 100% accurate.